DI
TEVA icon

Dalton Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Dalton Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-32,431
Closed -$244K – 29
2022
Q2 		$244K Hold
32,431
– – 0.22% 26
2022
Q1 		$305K Hold
32,431
– – 0.21% 19
2021
Q4 		$260K Hold
32,431
– – 0.17% 20
2021
Q3 		$316K Hold
32,431
– – 0.23% 19
2021
Q2 		$321K Hold
32,431
– – 0.18% 25
2021
Q1 		$374K Sell
32,431
-62,119
-66% -$712K 0.2% 28
2020
Q4 		$912K Sell
94,550
-20,173
-18% -$193K 0.45% 30
2020
Q3 		$1.03M Hold
114,723
– – 0.68% 28
2020
Q2 		$1.42M Hold
114,723
– – 1.03% 26
2020
Q1 		$1.03M Buy
+114,723
New +$1.18M 0.8% 28

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Dalton Investments's TEVA Position: Q3 2022 in Review

Dalton Investments sold out of Teva Pharmaceuticals (TEVA) in Q3 2022, closing a stake of 32,431 shares — an estimated $244K sold.

Dalton Investments first reported a position in TEVA in Q1 2020 and held it in 10 quarters. The position peaked at $1.42M in Q2 2020. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Dalton Investments reported no remaining Teva Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Dalton Investments sold 32,431 Teva Pharmaceuticals shares in Q3 2022, an estimated $244K.
  • Dalton Investments first reported a position in Teva Pharmaceuticals in Q1 2020 and held it in 10 quarters.
  • Dalton Investments's Teva Pharmaceuticals position peaked at $1.42M in Q2 2020.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Dalton Investments's 13F filing for Q3 2022, filed 14 Nov 2022.